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background: In spite of tremendous efforts by a number of groups, the search for single nucleotide polymorphisms (SNPs) strongly
associated with male factor infertility by means of gene re-sequencing studies has yielded few likely candidates. A recent pilot, genome-wide
SNP association study (GWAS) identified a list of SNPs associated with oligozoospermia and azoospermia. This is an expanded follow-up
study of the SNPs identified by the GWAS as well as other SNPs from previously published gene re-sequencing studies.
methods: On the basis of the pilot GWAS and SNPs with published associations with male infertility, 172 SNPs were genotyped in men
with idiopathic azoospermia or oligozoospermia using the Illumina BeadXpressw platform.
results: Several SNPs were identified or confirmed to be significantly associated with oligozoospermia and/or azoospermia. More
importantly, this follow-up study indicates that, at least in Caucasian men, no single common SNP accounts for a significant proportion
of spermatogenic failure cases.
conclusions: The associations reported in this study are promising, but much larger genome-wide studies will be necessary to con-
fidently validate these SNPs and identify novel SNPs associated with male infertility.
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Introduction
Infertility affects approximately one in seven couples worldwide result-
ing in significant financial and emotional costs, and male factor inferti-
lity accounts for about half of all infertility cases. Despite its
prevalence, infertility research has received much less attention than
most common, complex diseases.
Common known genetic causes of male infertility include Klinefel-
ter’s syndrome and Y chromosome microdeletions, both resulting in
severe oligozoospermia or azoospermia, and cystic fibrosis transmem-
brane conductance regulator mutations, which result in congenital
bilateral absence of vas deferens leading to obstructive azoospermia
(Nuti and Krausz, 2008). Taken together, known genetic causes of
male infertility account for less than one-third of all male factor infer-
tility cases leaving a large proportion of cases classified as idiopathic
(Dohle et al., 2002).
Due to the limited attention given to male infertility research and a
concomitant lack of substantial research funding, the majority of
research has focused on targeted gene re-sequencing studies in
search of genetic risk factors. Although several single nucleotide poly-
morphisms (SNPs) associated with various classes of male infertility
have been reported, for the majority, associations are weak and repli-
cation studies often fail to validate initial findings. To date only a single
pilot genome-wide SNP association study (GWAS) has been per-
formed for idiopathic male infertility (Aston and Carrell, 2009). In
this pilot study from our laboratory, no single SNP reached the level
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of genome-wide significance after adjusting for multiple comparisons
(Bonferroni adjustment), however, we did find 20 SNPs with a raw
P-value for association ,1 × 1025 and an estimated false discovery
rate of ,0.3 (Aston and Carrell, 2009).
Although the pilot GWAS represented an important first step in
the search for genetic variants associated with severe oligozoospermia
and non-obstructive azoospermia on a genome-wide scale, the study
evaluated a limited number of samples and the associations detected
were marginal for a GWAS. In the initial study, we stressed the need
for follow-up studies with increased sample size to evaluate the pre-
liminary results. For the present study, we have evaluated a larger
population of azoospermic and oligozoospermic men utilizing BeadX-
pressw (Illumina Inc., San Diego, CA, USA) technology as a cost effec-
tive medium-throughput assay for a targeted genotyping follow-up of
the findings of the initial study. Additionally, we have simultaneously
genotyped this population of men for SNPs identified in prior gene
re-sequencing studies and target genes of spermatogenesis. We eval-
uated the data for the follow-up study separately, and after combining
with the data from the initial GWAS.
Materials and Methods
Study samples
Details of patient and control selection for the pilot microarray study were
published previously (Aston and Carrell, 2009). Caucasian individuals of
central European descent, including normospermic controls (n ¼ 80)
with .20 million sperm/ml, severe oligozoospermic individuals (n ¼ 50)
with ,5 million sperm/ml and non-obstructive azoospermic individuals
(n ¼ 33) with no detectable sperm in the ejaculate following evaluation
of the centrifuged pellet and with no other known etiology, were included
in the study.
Patient and control samples used in the follow-up targeted genotyping
study included individuals of European decent-primarily of Mediterranean
origin. Infertile patients included in the study were seeking a complete
andrological diagnostic work-up for couple infertility. All infertile patients
were defined as ‘idiopathic’ and selected on the basis of a comprehensive
andrological examination including medical history and physical examin-
ation, semen analysis, scrotal ultrasound, hormone analysis, karyotype
and Y chromosome microdeletion screening. Patients with mono or bilat-
eral cryptorchidism, varicocele, previous testis trauma, obstructive azoos-
permia, recurrent infections, iatrogenic infertility, hypogonadotrophic
hypogonadism, karyotype anomalies or Y chromosome microdeletions
including gr/gr deletions were excluded.
In all, 158 normospermic controls (.20 million sperm/ml), 141 severe
oligozoospermic individuals (,5 million sperm/ml) and 80 non-
obstructive azoospermic individuals were included in the follow-up
study. In addition, 63 moderately oligozoospermic individuals (5–
10 million sperm/ml) were analyzed, and associations with all oligozoos-
permic men are reported separately.
DNA extraction
DNA was extracted from whole blood using the Gentra Puregene
Blood Kit (Qiagen Inc., Valencia, CA, USA) according to manufacturer’s
recommendations. Briefly, red blood cells were lysed, and white cells
pelleted followed by white cell lysis. Protein precipitation solution was
added and lysis solution spun to remove proteins. DNA was then
precipitated using 100% isopropanol, washed and re-suspended in
Tris-EDTA. DNA concentration was assessed using the NanoDrop
1000 spectrophotometer (Thermo Scientific, Waltham, MA, USA) and
subsequently adjusted to 50 ng/ml. Purified DNA was stored at
2808C prior to use.
Follow-up targeted genotyping assay design
A total of 84 SNPs were evaluated as a follow-up to the initial GWAS,
microarray pilot study. Three different groups of SNPs were selected for
follow-up based on associations detected in the microarray phase of the
study. Since the pilot study was limited in its power to detect by the rela-
tively small sample size, we used a lower threshold P-value for selection of
SNPs for the follow-up study. This was done to improve our chances of
validating true associations in spite of the lack of power. SNPs with a
P-value for association ,5 × 1025 (n ¼ 32), SNPs located within 10 kb
of genes with known fertility function based on phenotype in mouse
gene knockout models (Bult et al., 2008; Matzuk and Lamb, 2008) with
a P-value for association ,5 × 1023 (n ¼ 20), and non-synonymous
SNPs with a P-value for association ,5 × 1023 (n ¼ 32) were selected
for follow-up with additional samples (Table I).
In addition to SNPs with significant associations based on the microarray
pilot study, 21 SNPs associated with spermatogenic defects reported in lit-
erature (Table II) were evaluated as well as 67 non-synonymous SNPs
located within genes important in spermatogenesis (Table I). SNPs tar-
geted for genotyping based on previous publications were located in
AHRR, BRCA2, ER beta, ERCC1, ESR1, FASLG FHL5, FKBP6, IL1B,
KIT, MS, MTHFR, MTRR, PRM1, TSSK4, UBE2B and YBX2 (Table II).
Non-synonymous SNPs in spermatogenesis genes included SNPs in AR,
BRDT, CAMK4, CREM, DDX25, DMC1, FHL5, JMJD1A, KIF17, MSH4,
MSH5, PRM1, PRM2, REC8, SMC1B, SPATA22, SPO11, STRA8, SYCP1,
SYCP2, TEX11, TEX14, TEX15, TNP1, TNP2, USP26 and YBX2
(Table III). In all, the final BeadXpress assay targeted 172 SNPs (Table I).
Follow-up genotyping
Genotyping was performed on purified DNA samples using the Illumina
BeadXpressw Assay (Illumina Inc., San Diego, CA, USA) according to
manufacturer’s recommendations. Briefly, DNA was purified from periph-
eral blood lymphocytes as described above. Approximately 500 ng of pur-
ified DNA at a concentration of 50 ng/ml was delivered to the University
of Utah Genomics Core Facility (Salt Lake City, UT, USA) for genotyping
where it was prepared by several activation and ligation steps followed by
universal PCR and finally hybridization to SNP-specific genotyping beads.
Following hybridization and wash steps, reaction plates were scanned,
the raw data were normalized across samples and genotype calls were
made using BeadStudio Softwarew (Illumina Inc).
Genotype and haplogroup
association analysis
Associations were tested using GoldenHelixw SVS7 analysis software
(Bozeman, MT, USA). Initial data cleanup was performed to remove
poorly performing probes and samples from analysis. Probes with a call
rate ,0.95 and probes with significant deviations from Hardy–Weinberg
equilibrium (HWE) within controls of P, 0.001 were removed prior to
association analysis. Samples with a call rate of ,0.85 were also
removed from analysis.
SNP association analysis was performed applying allelic, additive, domi-
nant and recessive models to the data. Allelic association was performed
on autosomal probes, whereas all probes were analyzed using the other
models. Primary comparisons made for association testing included azoos-
permic versus normospermic (AvN), severe oligozoospermic versus nor-
mospermic (OvN) and azoospermic and severe oligozoospermic
combined versus normospermic (A+OvN). Only severe oligozoospermic
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Table I Details of SNPs genotyped
Markers
not
analyzed
Design
Category
SNP ID Chromosome Nearest
gene
Coding
status
Markers
not
analyzed
Design
category
SNP ID Chromosome Nearest
gene
Coding
status
CR M rs2472493 9 ABCA1 NC M rs300503 12 NAV3 NC
M rs10491278 5 AFF4 NC CR M rs1142530 19 NDUFS7 NS
M rs4705873 5 AFF4 NC M rs12913 16 NKD1 NC
P rs2292596 5 AHRR NS M rs1400699 2 NR4A2 NC
MAF 0 S rs9332968 X AR NS M rs11196389 10 NRAP NS
MAF 0 S rs9332970 X AR NS CR M rs9825719 3 NSUN3 NC
CR M rs9814870 3 ARL6 NC M rs1399645 2 NXPH2 NC
M rs6763208 3 ARL6 NC M rs2063802 2 NXPH2 NC
M rs2290870 4 ATP8A1 NC M rs4954657 2 NXPH2 NC
M rs8100856 19 ATP8B3 NS M rs11204546 1 OR2W3 NS
P rs144848 13 BRCA2 NS M rs1491584 2 PAX8 NC
MAF 0 S rs34674879 1 BRDT NS M rs2863242 2 PAX8 NC
S rs10747493 1 BRDT NS M rs4849179 2 PAX8 NC
S rs10783071 1 BRDT NS M rs1047854 19 PCSK4 NC
S rs3088232 1 BRDT NS M rs10841496 12 PDE3A NC
M rs11577579 1 C1orf125 NS M rs4926219 19 PKN1 NS
M rs3746804 20 C20orf54 NS M rs1046116 12 PKP2 NS
MAF 0 S rs35548075 5 CAMK4 NS M rs16981262 19 PLA2G4C NC
CR M rs735295 12 CCDC77 NS P rs2301365 16 PRM1 NC
M rs11264963 1 CD1E NC S rs35576928 16 PRM1 NS
M rs2072671 1 CDA NS CR S rs3177008 16 PRM2 NS
CR M rs3130981 6 CDSN NS M rs4484160 3 PROK2 NC
M rs11707608 3 CNTN3 NC M rs4450678 20 PTPRT NC
M rs2976084 3 CNTN3 NC CR S rs35425516 14 REC8 NS
M rs1545125 7 COBL NC MAF 0 S rs34075659 14 REC8 NS
MAF 0 S rs34227693 10 CREM NS M rs2291219 8 RPESP NS
MAF 0 S rs561704 11 DDX25 NS M rs6531 6 RXRB Syn
MAF 0 S rs2227914 22 DMC1 NS M rs6068020 20 SALL4 NC
M rs529208 9 DOCK8 NS M rs11435 5 SH3RF2 NS
M rs6444952 3 EIF5A2 NC M rs6476866 9 SLC1A1 NC
P rs1256049 14 ER beta Syn CR M rs4884207 13 SLITRK1 NC
P rs3212986 19 ERCC1 NC CR S rs9614653 22 SMC1B NS
P ESR1325C.G 6 ESR1 Syn MAF 0 S rs12157922 22 SMC1B NS
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Table I Continued
Markers
not
analyzed
Design
Category
SNP ID Chromosome Nearest
gene
Coding
status
Markers
not
analyzed
Design
category
SNP ID Chromosome Nearest
gene
Coding
status
P rs2234693 6 ESR1 NC MAF 0 S rs16993928 22 SMC1B NS
M rs7342883 17 EVPL NS S rs5764698 22 SMC1B NS
P rs763110 1 FASL NC M rs7224496 17 SMYD4 NS
CR P rs2273621 6 FHL5 NC MAF 0 S rs12602543 17 SPATA22 NS
P rs9398152 6 FHL5 NC S rs1488690 17 SPATA22 NS
S rs35157931 6 FHL5 NS S rs2291604 17 SPATA22 NS
S rs9373985 6 FHL5 NS MAF 0 S rs28368082 20 SPO11 NS
MAF 0 P rs3750075 7 FKBP6 NC MAF 0 S rs3736832 20 SPO11 NS
M rs11114486 12 FLJ90579 NS M rs7746261 6 SSR1 NS
M rs2083098 2 FMNL2 NC MAF 0 S rs12669242 7 STRA8 NS
M rs2032278 18 GALR1 NC MAF 0 S rs1053812 1 SYCP1 NS
tr9.CR M rs4343755 4 GNPDA2 NC MAF 0 S rs12563933 1 SYCP1 NS
M rs11718848 3 GOLGA4 NS CR S rs3736763 20 SYCP2 NS
M rs983034 1 GPR177 NS MAF 0 S rs1359836 20 SYCP2 NS
M rs10492239 12 GPR19 NC MAF 0 S rs6128714 20 SYCP2 NS
M rs12213993 6 HSF2 NC S rs6071006 20 SYCP2 NS
M rs3778348 6 HSF2 NC M rs10246939 7 TAS2R38 NS
M rs9375131 6 HSF2 NC M rs1726866 7 TAS2R38 NS
P rs1143634 2 IL1B Syn M rs2010834 18 TCEB3B NS
M rs2059807 19 INSR NC M rs4255473 10 TCF7L2 NC
CR M rs7146310 14 IPO4 NS S rs4844247 X TEX11 NS
MAF 0 S rs11677451 2 JMJD1A NS S rs6525433 X TEX11 NS
S rs2030259 2 JMJD1A NS CR S rs35551271 17 TEX14 NS
S rs34605051 2 JMJD1A NS MAF 0 S rs34960869 17 TEX14 NS
S rs2296225 1 KIF17 NS MAF 0 S rs35081269 17 TEX14 NS
S rs522496 1 KIF17 NS MAF 0 S rs35195402 17 TEX14 NS
S rs631357 1 KIF17 NS MAF 0 S rs35927726 17 TEX14 NS
P rs3819392 4 KIT NC MAF 0 S rs7220834 17 TEX14 NS
M rs268917 19 KLK4 NC S rs389389 17 TEX14 NS
M rs981684 17 KRT25C NS CR S rs323347 8 TEX15 NS
M rs6755901 2 LHCGR NC MAF 0 S rs9297162 8 TEX15 NS
M rs5911500 X LOC203413 NC S rs323343 8 TEX15 NS
M rs7889596 X LOC203413 NC S rs323344 8 TEX15 NS
M rs4541736 6 LRFN2 NC S rs323345 8 TEX15 NS
M rs215702 7 LSM5 NC S rs323346 8 TEX15 NS
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CR M rs12920268 16 MAF NC M rs3777654 6 TINAG NC
M rs3105782 3 MASP1 NC M rs11800462 1 TNFRSF25 NS
M rs3795958 2 MGC16372 NS MAF 0 S TNP188GA 2 TNP1 NS
HWE M rs9610624 22 MGC35206 NS MAF 0 S TNP217AG 16 TNP2 NS
CR M rs10848911 12 MGC4266 NC S rs34904070 16 TNP2 NS
M rs11024970 11 MRGPRX2 NS S TNP2391CT 16 TNP2 NS
P rs1805087 1 MS NS CR M rs2283817 22 TPST2 NC
CR S rs5745325 1 MSH4 NS MAF 0 P TSSK4987+108G.A 14 TSSK4 NC
MAF 0 S rs5745329 1 MSH4 NS P rs17167484 5 UBE2B NC
S rs5745549 1 MSH4 NS P rs3777373 5 UBE2B NC
CR S rs28381359 6 MSH5 NS M rs3736563 3 UBP1 NS
S rs1802127 6 MSH5 NS MAF 0 S rs4582709 X USP26 NS
S rs28381349 6 MSH5 NS S rs35397110 X USP26 NS
S rs28399977 6 MSH5 NS CR P YBX2intr6 17 YBX2 NC
P rs1801133 1 MTHFR NS CR S rs391768 17 YBX2 NS
M rs12537 22 MTMR3 NC P YBX2exon8 17 YBX2 Syn
P rs1801394 5 MTRR NS CR M rs2704838 X ZFX NC
M rs3826942 19 MUM1 NS M rs12912744 15 ZNF690 NS
Markers not analyzed: associations were not tested on some markers due to genotyping call rate ,0.95 (CR), deviation from HWE (P, 0.001) or a lack of the minor alleles in all samples (MAF 0). Design category: selection of SNPs for study was
based on previous microarray results (M), SNPs with previously published associations with infertility (P) or non-synonymous SNPs in spermatogenesis genes (S). Coding Status: SNPs analyzed were categorized as non-coding (NC),
non-synonymous (NS) or synonymous (Syn).
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Table II SNPs selected for study based on previously published reports of association with male infertility
SNP Gene Coding
status
Cases Controls Ethnicity Results Reference
rs2292596 AHRR NS 112 azoo/oligos 212 normo
controls
Estonian GG 31.5% cases, 18% contr P ¼ 0.006 Merisalu et al.
(2007)
rs144848 BRCA2 NS 240 azoo/sev oligo 250 proven fertiles Western
Chinese
C 23.5% cases, 17.6% contr Zhoucun et al.
(2006)
rs1256049 ER beta S 106 sev oligo, 86 test. cancer pts, 51
hypospadias, 23 cryptorchid
186.5 million/ml Caucasian AG 13.2% cases, 4.3% contr Aschim et al.
(2005)
rs3212986 ERCC1 NC 202 azoo 187 fert contr Chinese A 31.7% cases, 21.7% contr P ¼ 0.002 Ji et al. (2008)
ESR1325C.G ESR1 S 31 azoo 46 fert conrt Japanese CG+GG 90% cases, 66% contr P, 0.01 Suzuki et al.
(2002)
rs2234693 ESR1 NC 104 azoo/sev oligo 95 unselected
contr
Spanish TT 40.4% cases, 31.6% contr P ¼ 0.006 Galan et al. (2005)
rs763110 FASL NC 161 azoo/23 sev oligo 236 fert contr Chinese TT 10.3% cases, 3.8% contr P ¼ 0.008 Wang et al. (2009)
rs2273621 FHL5 NC 47 azoo/49 sev oligo 69 fert contr Caucasian A 76% cases 62% P ¼ 0.0072 Christensen et al.
(2006)
rs9398152 FHL5 NC 47 azoo/49 sev oligo 69 fert contr Caucasian T 92% cases, 81% contr P ¼ .0023 Christensen et al.
(2006)
rs3750075 FKBP6 NC 323 azoo/sev oligo 205 fert contr Western
Chinese
A 1.7% cases, 5.4% contr P ¼ 0.0007 Zhang et al.
(2007)
rs1143634 IL1B S 435 non-normo cases (incl 95 OAT) 127 normo contr Caucasian TT 7% of all cases, 1% contr, 14% OAT P ¼ 0.001 OAT
versus contr
Bentz et al. (2007)
rs3819392 KIT NC 167 azoo/sev oligo 465 unselected
contr
Spanish A 30.1% cases, 37.9% contr P ¼ 0.01 Galan et al. (2006)
rs1805087 MS NS 174 azoo, 186 OAT 325 fert contr Korean GG 3.1% cases, 1.2% contr P ¼ 0.09 GG sig increased
in azoos w/MTHFR 677 CC P ¼ 0.018
Lee et al. (2006)
rs1801133 MTHFR NS 174 azoo, 186 OAT 325 fert contr Korean TT 17.8% cases, 12.6% contr P ¼ 0.048 Lee et al. (2006)
rs1801133 MTHFR NS 179 OAT 200 fert contr Indian TT 11.7% cases, 15% contr P ¼ 0.15 Dhillon et al.
(2007)
rs1801133 MTHFR NS 151 azoo/sev oligo 200 fert contr Indian TT 4% cases, 0 contr P ¼ 0.004 Singh et al. (2005)
rs1801133 MTHFR NS 228 azoo, 127 sev oligo 252 fert, normo
contr
Chinese TT 21% azoos, 13.4% oligos, 11.5% contr P ¼ 0.023
cases versus contr, P ¼ 0.004 azoos versus contr
A et al. (2007)
rs1801133 MTHFR NS 286 azoo, 59 sev OAT, 26 OAT, 2
oligo
396 fert contr Korean TT 16.9% cases, 12.9% contr P ¼ 0.019 Park et al. (2005)
rs1801133 MTHFR NS 93 infert 105 fert contr Italian TT 20.4% cases, 27.6% contr not sig. Stuppia et al.
(2003)
rs1801133 MTHFR NS 77 subfertile 113 fert contr Caucasian TT 9.1% cases, 13.3% contr not sig. Ebisch et al.
(2003)
rs1801133 MTHFR NS 255 infert 200 contr Caucasian TT 18.8% cases, 9.5% contr P ¼ .008 Bezold et al.
(2001)
rs1801394 MTRR NS 174 azoo, 186 OAT 327 fert contr Korean GG 12.8% cases, 8.9% contr P ¼ 0.047 Lee et al. (2006)
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Table III Non-synonymous SNPs selected for study
based on gene function
Gene SNP Function
AR rs9332968 Transcription factor for androgen-responsive
genes
rs9332970
BRDT rs34674879 Transcriptional regulation during
spermatogenesis
rs10747493
rs10783071
rs3088232
CAMK4 rs35548075 Transcriptional regulation during
spermatogenesis
CREM rs34227693 Role in spermatogenesis and spermatid
maturation
DDX25 rs561704 mRNA export and translation during
spermatid development
DMC1 rs2227914 Meiotic recombination
FHL5 rs35157931 Activates CREM
rs9373985
JMJD1A rs11677451 Histone demethylase, regulates chromatin
packaging during spermatogenesis
rs2030259
rs34605051
KIF17 rs2296225 Regulates subcellular distribution of FHL5
rs522496
rs631357
MSH4 rs5745325 Meiotic recombination
rs5745329
rs5745549
MSH5 rs28381359 DNA mismatch repair, meiotic
recombination
rs1802127
rs28381349
rs28399977
PRM1 rs35576928 Sperm chromatin compaction
PRM2 rs3177008 Sperm chromatin compaction
REC8 rs35425516 Homologous chromosome and sister
chromatid separation
rs34075659
SMC1B rs9614653 Synapsis and meiotic recombination
rs12157922
rs16993928
rs5764698
SPATA22 rs12602543 Testes development
rs1488690
rs2291604
SPO11 rs28368082 DNA double stand breaks during meiosis
rs3736832
STRA8 rs12669242 Initiation of meiosis
SYCP1 rs1053812 Component of synaptonemal complex
Continued
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samples were included in the initial analysis to match the phenotypes
included in the pilot GWAS.
In addition to the primary comparisons, an additional aim of the study
was to evaluate the question of whether azoospermia or severe oligozoos-
permia result from SNPs specific to each individual infertility phenotype, or
whether SNPs common to both of these groups result in differing severi-
ties of spermatogenic defects. In order to address this question, oligozoos-
permic and normospermic data combined served as the control group and
were compared with azoospermic individuals (A versus O+N), and
conversely azoospermic and normospermic groups were combined and
compared with oligozoospermic individuals (O versus A+N). A P-value
of ,0.05 was considered significant.
In addition to a univariate analysis to evaluate the association between
single SNPs and spermatogenic defects, haplogroup association was also
performed to evaluate whether a specific haplogroup was more powerful
in predicting a phenotype than a single SNP. For this analysis, a moving
window of 100 kb was used to define haplogroups. The expected-
maximization (EM) algorithm with 50 iterations and a convergence toler-
ance of 0.0001 was employed for haplotype estimation (Excoffier and
Slatkin, 1995). A P-value of ,0.05 for association was considered
significant.
As haplogroup association assumes linkage between SNPs, additional
analysis was performed to determine whether azoospermic and oligozoos-
permic samples carried more total independent risk SNPs compared with
controls based on associations detected by univariate analysis. Differences
in total numbers of risk SNPs between groups were evaluated using the
un-paired Student’s t-test.
Oligozoospermic sperm count and
genotype analysis
For SNPs found to be associated specifically with oligozoospermia, further
analysis was performed to determine whether an association between the
‘risk allele’ and sperm concentration existed. To perform this analysis,
samples were grouped based on genotype for each associated SNP, and
sperm concentrations were compared between groups.
Results
Sample quality
There were 158 normospermic controls, 63 moderately oligozoo-
spermic samples, 141 severe oligozoospermic samples and 80 non-
obstructed azoospermic samples analyzed by BeadXpressw assay.
Poorly performing samples with genotyping call rates of ,0.85 (n ¼
2 severe oligozoospermic samples) were removed from association
testing leaving 158 controls, 63 moderately oligozoospermic
samples, 139 severe oligozoospermic samples and 80 azoospermic
samples. Five samples were run in duplicate across plates, and
average SNP concordance between samples was 99% across all
markers.
Genotype associations for microarray
follow-up SNPs
Association data from the pilot microarray study were recently pub-
lished (Aston and Carrell, 2009). A total of 84 markers were designed
to target SNPs as a follow-up to results obtained following a pilot
genome-wide association study. Probes with a call rate ,0.95 (n ¼
13), and probes with significant deviations from HWE within controls
of P, 0.001 (n ¼ 1), were removed prior to association analysis,
leaving 70 markers for analysis.
Of the 70 SNPs evaluated for association in the follow-up study
based on associations detected in the pilot study, four SNPs displayed
improved associations upon combining genotypes from the two pro-
jects (Table IV).
Genotype associations for published and
spermatogenesis gene SNPs
Additionally, 67 non-synonymous SNPs in genes important in sperma-
togenesis, and 21 SNPs with published associations with spermato-
genic defects for a total of 88 SNPs were genotyped. Because 11
markers had a call rate of ,0.95, they were removed, leaving 77
markers included in the analysis.
Of the 77 SNPs evaluated for association based on previously pub-
lished associations or SNP function, 31 displayed a minor allele fre-
quency of 0 in our study population, so those SNPs were not
included in association analysis. The remaining 46 SNPs were tested
for association with azoospermia or oligozoospermia, and five SNPs
were found to have significant associations at P, 0.05 (Table IV).
........................................................................................
Table III Continued
Gene SNP Function
rs12563933
SYCP2 rs3736763 Component of synaptonemal complex
rs1359836
rs6128714
rs6071006
TEX11 rs4844247 Regulates meiotic crossovers
rs6525433
TEX14 rs35551271 Formation of germ cell intercellular bridges
rs34960869
rs35081269
rs35195402
rs35927726
rs7220834
rs389389
TEX15 rs323347 Chromosomal synapsis
rs9297162
rs323343
rs323344
rs323345
rs323346
TNP1 TNP188GA Intermediate protein in sperm chromatin
compaction
TNP2 TNP217AG Intermediate protein in sperm chromatin
compaction
rs34904070
TNP2391CT
USP26 rs4582709 Ubiquitin-dependent proteolytic pathway in
testis
rs35397110
YBX2 rs391768 Stabilization of testis mRNAs
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Table IV SNPs with significant associations with azoospermia, severe oligozoospermia or all infertiles
Design
category
Test SNP ID Chromosome Gene Microarray
P
Targeted
genotyping
P A/SO/N
samples
Microarray1 targeted
genotyping combined
P A/SO/N samples
Minor
Allele
Major
Allele
Cases Controls
%
D
%
DD
%
Dd
%
dd
%
D
%
DD
%
Dd
%
dd
P SOvN
dom
rs763110 1 FASLG NA 2.81 × 1023 NA A G 0.50 0.19 0.60 0.20 0.36 0.12 0.49 0.39
S AvN rec rs34605051 2 JMJD1A NA 3.23 × 1023 NA G A 0.18 0.08 0.21 0.71 0.16 0.01 0.30 0.69
M SOvN add rs5911500 X LOC203413 4.77 × 1025 4.21 × 1023 8.32 × 1027 T C 0.08 NA NA NA 0.27 NA NA NA
S A+SOvN
all
rs323344 8 TEX15 NA 8.22 × 1023 NA C A 0.08 0.01 0.14 0.84 0.15 0.04 0.22 0.75
S A+SOvN
all
rs323345 8 TEX15 NA 1.21 × 1022 NA G A 0.09 0.01 0.15 0.84 0.15 0.04 0.22 0.75
S SOvN rec rs3088232 1 BRDT NA 2.63 × 1022 NA G C 0.21 0.07 0.28 0.65 0.18 0.02 0.34 0.65
M A+SOvN
add
rs11204546 1 OR2W3 2.42 × 1024 4.60 × 1022 1.87 × 1024 T C 0.28 0.07 0.41 0.52 0.38 0.15 0.46 0.39
M SOvN all rs2059807 19 INSR 1.10 × 1024 4.74 × 1022 3.24 × 1024 T C 0.30 0.06 0.48 0.46 0.42 0.19 0.48 0.34
M AvN dom rs10246939 7 TAS2R38 1.45 × 1023 7.37 × 1022 7.24 × 1024 C T 0.33 0.10 0.44 0.45 0.48 0.24 0.49 0.27
SNPs are listed in order of significance based on P-value in the targeted genotyping study.
Design category: selection of SNPs for study was based on previous microarray results (M), SNPs with previously published associations with infertility (P) or non-synonymous SNPs in spermatogenesis genes (S). Test: describes the comparison
made for association testing as well as the genetic model applied for association testing. A, azoospermic; SO, severe oligozoospermic; N, normospermic; AvN, azoospermic versus normospermic; SOvN, severe oligozoospermic versus
normospermic; A+SOvN, azoospermic+severe oligozoospermic versus normospermic; add, additive; all, allelic; dom, dominant; rec, recessive; NA, SNPs not selected for follow-up based on initial microarray results; D, minor allele;
d, major allele.
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Interestingly, only one of these five significant SNPs was selected
based on previously published data. In other words, only one SNP
from previous re-sequencing studies showed significant association in
this study.
Effect of inclusion of moderate
oligozoospermic samples on
SNP associations
When moderately oligozoospermic samples were included along with
the severe oligozoospermic samples, associations for six SNPs
improved, whereas associations for eight SNPs declined (Table V).
SNP associations with inclusion of
alternative comparisons
When A versus O+N and O versus A+N comparisons were made,
associations improved for four SNPs that were significant using the
conventional A versus N, O versus N and A+O versus N compari-
sons. In addition, five more SNPs reached significance with the
added statistical power derived from a larger number of control
samples (Table V).
Haplogroup associations
A total of seven haplogroups were found to display significant associ-
ations with infertile phenotypes at P, 0.05 when A versus N, O
versus N and A+O versus N comparisons were made excluding mod-
erate oligozoospermia (Table VI). Including the comparisons A versus
O+N and O versus A+N in the association testing increased the
number of significant associations to nine. Inclusion of moderate oligo-
zoospermic patients in the oligozoospermia group resulted in
improved associations for only one haplogroup and reduced associ-
ations for three haplogroups (Table VII). Analysis of the number of
risk SNPs per sample revealed that, as expected, multiple risk SNPs
were present at a higher frequency in cases compared with controls
(P, 0.05).
Oligozoospermic sperm count and
genotype analysis
Comparison of mean sperm counts in oligozoospermic samples dis-
playing a ‘risk allele’ versus those without for the SNPs most signifi-
cantly associated with oligozoospermia revealed no difference in
sperm count between groups for any of the SNPs analyzed.
Discussion
The data presented here represents the most comprehensive SNP
study for male infertility performed to date. In all, genotype data for
147 SNPs across several hundred samples is reported. Of the 147
SNPs evaluated, we report significant associations for a total of 14
SNPs at P, 0.05 when all samples and comparisons were included
(Table V). It should be noted that the P-values for association reported
here have not been corrected for multiple comparisons. With 147
independent tests, a P-value of 0.0003 would be required to achieve
a Bonferroni-adjusted P-value of ,0.05.
The most significant association found in this study is for rs5911500.
This is an intergenic SNP located on the X chromosome 200 kb
from solute carrier family 6, member 14 (SLC6A14). On the basis
of the intergenic location of rs5911500, if the SNP is a functional
variant responsible for the oligozoospermia phenotype, it is most
likely involved in a regulatory capacity. Indeed, many SNPs associated
with a variety of complex diseases are located in gene deserts, provid-
ing further evidence that uncharacterized functional elements are
located in those regions (Easton and Eeles, 2008; Mathew, 2008).
Three SNPs located within receptor protein genes were signifi-
cantly associated with azoospermia or oligozoospermia. The SNP
rs2059807, associated with oligozoospermia, is an intronic SNP
located on chromosome 19 of the insulin receptor gene (INSR).
Rs11204546 is a non-synonymous SNP located in the olfactory recep-
tor, family 2, subfamily W, member 3 gene (OR2W3) on chromo-
some 1. This polymorphism is associated with both azoospermia
and severe oligozoospermia and results in a conservative Methionine
to Valine amino acid change. Rs10246939 is another non-synonymous
SNP located in the taste receptor, type 2, member 38 gene
(TAS2R38) on chromosome 7 and is associated specifically with
azoospermia. This SNP also results in a conservative amino acid
change of Isoleucine to Valine. Although none of these receptors
have been directly implicated in spermatogenesis, receptor proteins
of a variety of classes have been shown to be present in the testes
(Oonk and Grootegoed, 1987; Thomas et al., 1996).
SNPs with significant associations with spermatogenic failure were
also found in testis expressed 15 (TEX15), fas ligand (FASLG), bromo-
domain, testis-specific (BRDT) and lysine-specific demethylase 3A
(JMJD1A). The associated SNPs in TEX15, BRDT and JMJD1A all
result in conservative amino acid substitutions, and the SNP in
FASLG is a non-coding SNP located in the promoter region of the
gene. Each of these genes is specifically involved in spermatogenesis.
TEX15 was recently shown to be necessary for spermatogenesis
but not oogenesis. Knockout of the gene in mice resulted in early
meiotic arrest in males resulting in a complete lack of germ cells
(Yang et al., 2008). Further analysis revealed TEX15 is required for
normal chromosomal synapsis and that the protein is likely involved
in the loading of DNA repair machinery at the point of DNA double-
strand breaks, with gene loss resulting in the meiotic arrest as
observed in Tex15-deficient male mice (Yang et al., 2008). Although
the associated SNPs result in conservative amino acid changes to
the protein, a direct link to impaired spermatogenesis in unclear.
The SNP rs763110 in the promoter region of FASLG, a gene
involved in germ cell apoptosis induction, was recently shown by
meta-analysis to be associated with cancer susceptibility (Zhang
et al., 2009). This SNP was selected for study based on a recent
report of its association with male infertility (Wang et al., 2009). In
this report, azoospermic and severe oligozoospermic men together
more frequently carried the risk genotype than controls (Wang
et al., 2009). In contrast, we found the SNP to associate with
severe oligozoospermia, with no apparent association with
azoospermia.
The other two SNPs with significant associations with spermato-
genic failure both reside in genes involved in chromatin remodeling.
The SNP rs3088232, located in the gene BRDT is associated with
severe oligozoospermia in our study. BRDT is a testis-specific
protein that interacts with acetylated lysine residues of histones and
other proteins (Pivot-Pajot et al., 2003). Hyperacetylation of histones
occurs in male germ cells prior to histone-to-prtotamine replacement.
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Table V SNPs with significant associations with azoospermia, severe oligozoospermia or moderate oligozoospermia including alternate comparisons
Design
category
Test SNP ID Chromosome Gene Microarray
P
Targeted
genotyping
P A/SO/N
samples
Targeted
genotyping
P A/O/N
samples
Microarray 1
Targeted
genotyping
combined P
A/SO/N
samples
Microarray 1
Targeted
genotyping
combined P
A/O/N
samples
Minor
Allele
Major
Allele
Cases Controls
%
D
%
DD
%
Dd
%
dd
%
D
%
DD
%
Dd
%
dd
P OvA+N
dom
rs763110* 1 FASLG NA 1.60 × 1024 2.80 × 1024 NA NA A G 0.50 0.19 0.60 0.20 0.36 0.12 0.49 0.39
S AvO+N
rec
rs34605051* 2 JMJD1A NA 7.70 × 1024 3.88 × 1023 NA NA G A 0.18 0.08 0.21 0.71 0.16 0.01 0.30 0.69
M OvN add rs5911500* X LOC203413 4.77 × 1025 4.21 × 1023 1.45 × 1022 8.323 × 1027 2.91 × 1026 T C 0.08 0.08 0.00 0.92 0.27 0.27 0.00 0.73
M AvO+N
dom
rs10246939* 7 TAS2R38 2.13 × 1024 5.13 × 1023 2.72 × 1023 1.58 × 1025 7.82 × 1026 C T 0.33 0.10 0.44 0.45 0.50 0.24 0.51 0.25
S OvA+N
rec
rs3088232* 1 BRDT NA 6.38 × 1023 9.99 × 1023 NA NA G C 0.21 0.07 0.28 0.65 0.18 0.02 0.34 0.65
S A+OvN
all
rs323344* 8 TEX15 NA 8.22 × 1023 3.99 × 10 23 NA NA C A 0.08 0.01 0.14 0.84 0.15 0.04 0.22 0.75
S A+OvN
all
rs323345* 8 TEX15 NA 1.21 × 1022 5.68 × 1023 NA NA G A 0.09 0.01 0.15 0.84 0.15 0.04 0.22 0.75
S AvO+N
dom
rs5764698 22 SMC1B NA 1.93 × 1022 8.76 × 1023 NA NA A C 0.53 0.24 0.59 0.18 0.47 0.24 0.45 0.31
P OvA+N
rec
rs1801131 1 MTHFR NA 2.36 × 1022 8.07 × 1022 NA NA C A 0.29 0.14 0.31 0.55 0.28 0.07 0.42 0.51
S OvA+N
rec
rs631357 1 KIF17 NA 2.40 × 1022 1.52 × 1022 NA NA C G 0.19 0.04 0.29 0.66 0.16 0.01 0.30 0.69
S AvO+N
dom
rs35397110 X USP26 NA 2.45 × 1022 3.13 × 1022 NA NA A G 0.09 0.09 0.00 0.91 0.03 0.03 0.00 0.97
S AvO+N
all
rs2030259 2 JMJD1A NA 2.61 × 1022 2.64 × 1022 NA NA A G 0.31 0.14 0.35 0.51 0.23 0.07 0.32 0.61
M A+OvN
add
rs11204546* 1 OR2W3 2.42 × 1024 4.60 × 1022 9.45 × 1022 1.87 × 1024 6.67 × 1024 T C 0.28 0.07 0.41 0.52 0.38 0.15 0.46 0.39
M OvN all rs2059807* 19 INSR 1.10 × 1023 4.74 × 1022 2.32 × 1021 3.24 × 1024 4.26 × 1023 T C 0.30 0.06 0.48 0.46 0.42 0.19 0.48 0.34
SNPs are listed in order of significance based on P-value in the targeted genotyping study.
Design category: selection of SNPs for study was based on previous microarray results (M), SNPs with previously published associations with infertility (P) or non-synonymous SNPs in spermatogenesis genes (S). Test: describes the comparison
made for association testing as well as the genetic model applied for association testing. A, azoospermic; SO, severe oligozoospermic; O, oligozoospermic and severe oligozoospermic combined; N, normospermic; AvN, azoospermic versus
normospermic; OvN, severe oligozoospermic versus normospermic, A+OvN, azoospermic + oligozoospermic versus normospermic; AvO+N, azoospermic versus oligozoospermic + normospermic; OvA+N, oligospermic versus
azoospermic + normospermic; add, additive; all, allelic; dom, dominant; rec, recessive; *, denotes SNPs presented in Table IV; NA, SNPs not selected for follow-up based on initial microarray results; D, minor allele; d, major allele.
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It was recently reported that BRDT binds specifically to histone H4
tails with at least two acetylation marks (Moriniere et al., 2009).
The importance of this protein in spermatogenesis makes it an intri-
guing candidate for disruption of spermatogenesis.
JMJD1A is a histone demethylase that specifically demethylates
mono- and di-methylated histone H3 lysine 9. Knockout of Jmjd1a
in mice results in reduced testis weight and severe oligozoospermia
resulting in infertility (Liu et al., 2010). It was also found that Jmjd1a
knockout resulted in reduced expression of a number of genes impor-
tant in chromatin remodeling and spermatid elongation (Liu et al.,
2010). As with the other SNPs identified in this study, the functional
significance of rs34605051 is not yet known.
As with the majority of associations reported for other GWAS, the
involvement of the associated SNPs identified in this study is not
immediately clear. The variants identified may not be the actual func-
tional variants, but may be in linkage disequilibrium with the functional
variant, as has been determined for the majority of SNPs identified by
GWAS (Lettre and Rioux, 2008). Alternatively, the SNPs identified
may affect uncharacterized functional elements within the genome.
In a few cases, haplogroup analysis detected significant associations
in genes that were not found when evaluating individual SNPs such as
haplogroups in paired box 8 (PAX8) and transition protein 2 (TNP2),
however, in most cases no statistical power was gained by evaluating
haplogroups as compared with individual SNPs. Although our data
indicate that cases were significantly more likely than controls to
contain multiple independent risk SNPs, much larger studies will be
necessary to accurately characterize the combined effects of multiple
independent loci on spermatogenic defects.
In an effort to better characterize the genetic basis for different
categories of spermatogenic failure, we performed a number of
different comparisons for association testing. In the majority of pub-
lished male infertility SNP association studies the primary comparison
.............................................................................................................................................................................................
Table VI Haplogroups significantly associated with azoospermia, oligozoospermia or all infertiles
Design
Category
Comparison First
Marker
Chromosome Gene Haplotype EM cases
freq.
EM controls
freq.
x2 P A/
SO/N
samples
x2 P A/O/
N
samples
S OvN rs323343 8 TEX15 AAAGG 0.08 0.03 6.59 × 1023 8.98 × 1023
S A+OvN rs323343 8 TEX15 ACGGG 0.08 0.14 8.34 × 1023 1.83 × 1023
M AvN rs10246939 7 TAS2R38 AA 0.66 0.54 8.76 × 1023 8.76 × 1023
M OvN rs2863242 2 PAX8 AG 0.01 0.03 3.46 × 1022 1.59 × 1021
M OvN rs4849179 2 PAX8 AAG 0.01 0.03 3.70 × 1022 1.44 × 1021
S AvN rs34904070 16 TNP2 GAACC 0.30 0.22 4.60 × 1022 4.60 × 1022
S AvN rs323344 8 TEX15 CGGG 0.08 0.15 4.66 × 1022 4.66 × 1022
SNPs are listed in order of significance based on P-value in the targeted genotyping study.
Design category: selection of SNPs for study was based on previous microarray results (M), SNPs with previously published associations with infertility (P) or non-synonymous SNPs in
spermatogenesis genes (S). Test: describes the comparison made for association testing. A, azoospermic; SO, severe oligozoospermic; O, oligozoospermic and severe oligozoospermic
combined; N, normospermic; AvN, azoospermic versus normospermic; OvN, oligozoospermic versus normospermic; A+OvN, azoospermic + oligozoospermic versus normospermic;
D, minor allele; d, major allele.
.............................................................................................................................................................................................
Table VII Haplogroups significantly associated with azoospermia, severe oligozoospermia or moderate oligozoospermia
including alternate comparisons
Design
category
Test First
marker
Chromosome Gene Haplotype EM cases
freq.
EM controls
freq.
x2 PA/SO/N
samples
x2 P A/O/N
samples
M AvO+N rs10246939* 7 TAS2R38 AA 0.66 0.50 4.26 × 1024 3.05 × 1024
S OvN rs323343* 8 TEX15 AAAGG 0.08 0.03 6.59 × 1023 8.98 × 1023
S A+OvN rs323343* 8 TEX15 ACGGG 0.08 0.14 8.34 × 1023 1.83 × 1023
S AvO+N rs34904070* 16 TNP2 GAACC 0.30 0.21 1.59 × 1022 2.38 × 1022
S AvO+N rs2030259 2 JMJD1A GAA 0.51 0.61 1.60 × 1022 4.21 × 1022
M OvA+N rs4849179* 2 PAX8 AAG 0.01 0.03 1.92 × 1022 7.40 × 1022
S AvO+N rs2030259 2 JMJD1A AAA 0.31 0.23 2.60 × 1022 4.58 × 1022
M OvA+N rs2863242* 2 PAX8 AG 0.01 0.04 3.21 × 1022 1.04 × 1021
S AvN rs323344* 8 TEX15 CGGG 0.08 0.15 4.66 × 1022 4.66 × 1022
Design category: selection of SNPs for study was based on previous microarray results (M), SNPs with previously published associations with infertility (P) or non-synonymous SNPs in
spermatogenesis genes (S). Test: describes the comparison made for association testing as well as the genetic model applied for association testing. A, azoospermic; SO, severe
oligozoospermic; O, oligozoospermic and severe oligozoospermic combined; N, normospermic; AvN, azoospermic versus normospermic; OvN, oligozoospermic versus normospermic,
A+OvN, azoospermic + oligozoospermic versus normospermic; AvO+N, azoospermic versus oligozoospermic + normospermic; OvA+N, oligospermic versus azoospermic +
normospermic; *, denotes haplogroups presented in Table VI.
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is normospermic or known fertile controls compared with infertile
men. The infertile group sometimes includes only non-obstructive
azoospermic men or only severely oligozoospermic men, but often
azoospermic and oligozoospermic groups are combined. In combin-
ing azoospermic and oligozoospermic samples for association testing,
the assumption is that the same SNPs contribute to both pathol-
ogies. We performed these same comparisons (A versus N, O
versus N and A+O versus N), however, we also evaluated the
strength of associations with alternate comparisons (A versus
O+N and O versus A+N). In doing so, we test the assumption
that azoospermia and oligozoospermia are disorders with completely
separate genetic backgrounds. There is not a compelling amount of
evidence to support or refute either of these assumptions, so we
report here the significant associations for all of the comparisons
made.
A striking result of the current study is the failure of this study to
validate essentially all of the previously published SNPs associated
with azoospermia or oligozoospermia. Due to limitations of the
assay, we were not able to design probes to genotype all of the pre-
viously published male infertility SNPs, however, we did perform
association testing on 17 previously reported SNPs and found a signifi-
cant association for only one of those SNPs in our study group. In
addition, we performed follow-up association testing for 70 SNPs
with strong or marginal associations with azoospermia or oligozoos-
permia based on our pilot microarray study, and of those SNPs,
associations were strengthened for only four.
There are a number of possible reasons for this low rate of vali-
dation. Our pilot and follow-up studies both included Caucasians of
European decent; however, many of the previously published
re-sequencing studies included men of other ethnicities (Table II).
SNP and haplotype frequencies vary widely between ethnic groups.
It is, unfortunately, not uncommon for associations reported in one
study to fail validation in subsequent studies as a result of insufficient
study power, genetic homogeneity between or within studies, or
because the initially reported association was spurious (Krausz and
Giachini, 2007; Liu et al., 2008). This again emphasizes the need for
rigorous follow-up of reported associations in new patient groups
and by means of meta-analyses to achieve additional power when
possible (Tuttelmann et al., 2007; Nuti and Krausz, 2008).
On the basis of these findings, it is likely that male factor infertility is
similar in nature to the majority of complex diseases studied to date in
that the disease is multigenic and no single SNP is responsible for an
appreciable proportion of male factor infertility cases (Manolio et al.,
2009). It seems unlikely that a few SNPs of moderate or large effect
are responsible for spermatogenic failure, rather that a large number
of rare variants of small effect are responsible, as has been proposed
for other complex diseases (Manolio et al., 2009). Given the wide
phenotypic spectrum of male infertility or even non-obstructive
azoospermia, it is not surprising that SNPs with strong effect
have not been identified. In order to detect real associations for
such small effect SNPs, much larger genome-wide studies will be
necessary.
To date, genome-wide studies have successfully identified hun-
dreds of genetic variants associated with over 80 different diseases
or traits (Hindorff et al., 2009). Mounting evidence based on larger
and larger genome-wide studies suggests genotypes for tens or
even hundreds of thousands of cases and controls will be required
to capture an appreciable proportion of the loci responsible for
the heritable component of many common complex diseases
(Panoutsopoulou and Zeggini, 2009). For example, the genetic com-
ponent of type 2 diabetes (T2D) has been studied extensively over
the past few decades. Early gene re-sequencing efforts and genome-
wide linkage scans successfully identified four important loci associ-
ated with T2D over a span of almost 30 years (McCarthy and
Zeggini, 2009). In contrast, the first genome-wide SNP association
study of T2D was published in 2007 (Sladek et al., 2007), and in
,2 years a total of 15 new risk variants have been identified
(McCarthy and Zeggini, 2009).
Although this illustrates the incredible power to identify risk alleles
by genome-wide genotyping, a total of six studies cumulatively
genotyping over 7000 cases and 13 000 controls were employed
(McCarthy and Zeggini, 2009). Even with the large effort made to
understand the genetic component of T2D, the variants identified
to date still only account for about 6% of T2D heritability (Manolio
et al., 2009).
Similar results have been obtained for other complex diseases
including neurological disorders (Simon-Sanchez and Singleton, 2008;
Bertram and Tanzi, 2009), autoimmune diseases (Lettre and Rioux,
2008; Graham et al., 2009), cardiovascular disease (Arking and Chak-
ravarti, 2009) and a number of different cancers (Savas and Liu, 2009)
following multiple large genome-wide studies.
Although these data represent a promising and potentially impor-
tant group of associations, clearly much larger studies will be necess-
ary to validate these findings and identify new functional variants
associated with male infertility. It remains to be seen whether
studies evaluating hundreds or a few thousand infertile men will be
sufficient to identify risk variants with confidence or whether
studies similar in magnitude to the previously discussed diseases
will be required, but it is clear that studies need to be expanded sig-
nificantly if we want to obtain answers. In addition structural variants
such as duplications or deletions in the genome have been found to
be important risk factors in a number of complex diseases (Frazer
et al., 2009; Wain et al., 2009). In the case of male infertility, gr/
gr deletion of the Y chromosome (which removes half of the
AZFc genes) has been confirmed as a significant risk factor for
impaired spermatogenesis (Repping et al., 2003; Giachini et al.,
2008; Visser et al., 2009). Other types of variation may also prove
to be important in some cases of male factor infertility and should
be evaluated in future studies.
In summary, this is the first follow-up study of a small, pilot
genome-wide association study of azoospermia and oligozoospermia.
We have further evaluated the SNPs identified in the GWAS, along
with SNPs identified from re-sequencing studies and non-
synonymous SNPs from spermatogenesis genes, in Caucasian men
of European descent and have identified several SNPs of potential
relevance to oligozoospermia and azoospermia. Nevertheless, the
study also highlights the need for future large-scale genome-wide
association studies with increased statistical power, the need for
structural variation studies to identify relevant copy number vari-
ations, and the need for genome sequencing of individuals to identify
rare variants that are likely to be responsible for a significant pro-
portion of spermatogenic defects. Such studies are becoming techno-
logically practical, but will require profound improvements in
collaboration and funding.
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